C2N Diagnostics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

C2N Diagnostics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated November 4, 2025
Public ProfileLinkedInLinkedIn Profile

C2N Diagnostics is a specialty molecular diagnostics company dedicated to improving the early diagnosis and treatment of Alzheimer's disease and related neurodegenerative disorders.

Employees60
Revenue$18.1M
Total Funding115.7M

Industry & Market

Primary Industry
research
Location
St. Louis, Missouri, United States

Funding Information

Latest Stage
Other
Annual Revenue
$18,100,000

Headcount Distribution

Total Employees
60
Departments
19

By Department

Department Breakdown

Sales
Information Technology
Operations
Education
Legal
Data Science
Others

Keywords & Focus Areas

biotechnology researchbiomarker technologyclinical researchdiagnostic assay developmentalzheimers biomarker assaysneurodegenerative disease testingblood test for brain amyloidpatient caremedical laboratoriesglobal diagnostic partnershipsalzheimers disease biomarkersbiomarker detection technologyneurodegeneration biomarkersliquid biopsy technologyclinical research collaborationsbiomarker research collaborationshealthcarebiomarker measurementbiomarker validationdecentralized testing+10 more
30 total keywords

Overview

C2N Diagnostics is a specialty molecular diagnostics company dedicated to improving the early diagnosis and treatment of Alzheimer's disease and related neurodegenerative disorders. Founded by scientists from Washington University School of Medicine and LifeTech Research, the company operates a CLIA-certified laboratory in St. Louis, Missouri.

The organization utilizes advanced high-resolution mass spectrometry to identify and quantify protein biomarkers in blood, which are essential for diagnosing and monitoring brain disorders. Their flagship product, the PrecivityAD™ blood test, detects brain amyloid, a key indicator of Alzheimer's disease, and is available across most of the U.S., as well as holding a CE Mark in the European Union. The company is also pursuing FDA approval to further enhance accessibility of this test. C2N Diagnostics supports clinical decision-making, enhances clinical trial efficiency, and partners with pharmaceutical firms and academic institutions on research to advance Alzheimer's research and treatment worldwide.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
C2N Diagnostics
Headquarters
20 S Sarah St, St Louis, Missouri 63108, US
Founded
2007
Languages
English
Industry
research

Technology Stack

Analytics & Tracking

Not found

Social & Marketing

Not found

Database & Backend

Not found

Cloud & Infrastructure

Salesforce Service Cloud

Productivity

Not found

Compare similar companies to C2N Diagnostics

Compare insights from companies similar to C2N Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xxx
$5593651Private-3460
xxxxxxxx
xxx
$3002790Private-7794
xxxxxxxx
x
$1091811Private-2704
x
x
$65735132Private-7437
xxxxxx
x
$6143550Private-1375
xxxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free

Resources

Careers

Pricing

homeCommunity

Security

SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd.

LinkedInTwitterInstagramYouTube
AICPAGDPR
CCPAISO
LinkedInTwitterInstagramYouTube